Literature DB >> 16633360

Allogeneic bone marrow transplantation (BMT) for refractory Behçet's disease with severe CNS involvement.

A M Marmont, F Gualandi, G Piaggio, M Podestà, M Teresa van Lint, A Bacigalupo, F Nobili.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16633360     DOI： 10.1038/sj.bmt.1705372

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

1.  Stem cell transplantation for autoimmune diseases.

Authors:  Thomas Hügle; Thomas Daikeler
Journal:  Haematologica       Date:  2010-02       Impact factor: 9.941

2.  Behçet's Disease.

Authors:  Gulsen Akman-Demir; Sabahattin Saip; Aksel Siva
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

3.  CD4+ T cell-depleted lymphocyte infusion impairs neither the recovery of recipient thymus nor the development of transplanted thymus.

Authors:  Ming Shi; Ming Li; Yunze Cui; Lin Liu; Yasushi Adachi; Susumu Ikehara
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

4.  High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease.

Authors:  Charles F Henderson; Robert A Brodsky; Richard J Jones; Stuart M Levine
Journal:  Semin Arthritis Rheum       Date:  2011-02-03       Impact factor: 5.532

5.  Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature.

Authors:  Thomas Daikeler; Ina Kötter; Chiara Bocelli Tyndall; Jane Apperley; Andishe Attarbaschi; Philippe Guardiola; Alois Gratwohl; Esa Jantunen; Alberto Marmont; Ferdinando Porretto; Maurizio Musso; Britta Maurer; Nadia Rinaldi; Riccardo Saccardi; Alan Tyndall
Journal:  Ann Rheum Dis       Date:  2006-09-01       Impact factor: 19.103

Review 6.  Stem cell autograft and allograft in autoimmune diseases.

Authors:  Angelo De Cata; Angela Matarangolo; Michele Inglese; Rosa Rubino; Gianluigi Mazzoccoli
Journal:  Clin Exp Med       Date:  2014-12-14       Impact factor: 3.984

7.  Combination of intra-bone marrow-bone marrow transplantation and subcutaneous donor splenocyte injection diminishes risk of graft-versus-host disease and enhances survival rate.

Authors:  Ming Shi; Yasushi Adachi; Yunze Cui; Ming Li; Zhexiong Lian; Yuming Zhang; Seiji Yanai; Chieko Shima; Yuichiro Imai; Susumu Ikehara
Journal:  Stem Cells Dev       Date:  2010-12-22       Impact factor: 3.272

Review 8.  Mesenchymal stem cells as therapeutics.

Authors:  Biju Parekkadan; Jack M Milwid
Journal:  Annu Rev Biomed Eng       Date:  2010-08-15       Impact factor: 9.590

9.  Allogeneic stem cell transplantation for rheumatic autoimmune diseases.

Authors:  Thomas Hügle; Jacob M van Laar
Journal:  F1000 Med Rep       Date:  2010-03-25

10.  Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cells.

Authors:  You-Kang Chang; Ming-Hsiang Chen; Yi-Hung Chiang; Yu-Fan Chen; Wei-Hsien Ma; Chian-You Tseng; Bin-Wen Soong; Jennifer H Ho; Oscar K Lee
Journal:  J Biomed Sci       Date:  2011-08-08       Impact factor: 8.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.